DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)

Conditions:   HEPATITIS C;   DRUG USE Intervention:   Drug: Sofosbuvir 400 mg and Daclatasvir 60 mg Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials